Front Barnett Associates’s iShares Biotechnology ETF IBB Stock Holding History

Front Barnett Associates’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$345K	Sell	2,825 -8,502	-75%	-$1.08M	0.04%	92
2023 Q2	$1.44M	Hold	11,327	–	–	0.16%	55
2023 Q1	$1.46M	Hold	11,327	–	–	0.17%	54
2022 Q4	$1.49M	Hold	11,327	–	–	0.19%	57
2022 Q3	$1.32M	Hold	11,327	–	–	0.17%	55
2022 Q2	$1.33M	Hold	11,327	–	–	0.16%	58
2022 Q1	$1.48M	Hold	11,327	–	–	0.15%	59
2021 Q4	$1.73M	Hold	11,327	–	–	0.16%	57
2021 Q3	$1.83M	Hold	11,327	–	–	0.19%	55
2021 Q2	$1.85M	Buy	+11,327	New	+$1.74M	0.19%	55

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Front Barnett Associates's IBB Position: Q3 2023 in Review

Front Barnett Associates reduced its iShares Biotechnology ETF (IBB) stake by 75% in Q3 2023, selling an estimated $1.08M and leaving 2,825 shares worth $345K. The position accounts for 0.04% of the portfolio, ranked #92.

Front Barnett Associates first reported a position in IBB in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.85M in Q2 2021. 833 funds tracked by Wall St. Rank hold IBB as of Q3 2023.

Front Barnett Associates held 2,825 shares of iShares Biotechnology ETF worth $345K as of Q3 2023.
Front Barnett Associates sold 8,502 iShares Biotechnology ETF shares in Q3 2023, an estimated $1.08M.
iShares Biotechnology ETF made up 0.04% of Front Barnett Associates's portfolio in Q3 2023, its #92 holding.
Front Barnett Associates first reported a position in iShares Biotechnology ETF in Q2 2021 and has held it in 10 quarters since.
Front Barnett Associates's iShares Biotechnology ETF position peaked at $1.85M in Q2 2021.
833 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2023.

Based on Front Barnett Associates's 13F filing for Q3 2023, filed 13 Nov 2023.